PMI Earns "Triple-A" Rating for Environmental Leadership

Apr.08.2022
PMI Earns "Triple-A" Rating for Environmental Leadership
PMI aims to be a global environmental leader, earning a "triple-A" rating from the CDP for their efforts.

Philip Morris International (PMI) is committed to becoming a global environmental leader, having been awarded a "AAA" rating for its performance and leadership in addressing climate change and protecting forests and water safety.

 

This is the second year that the international nonprofit charity CDP has recognized PMI's efforts in disclosing its environmental impact, aiding the company in its transparency efforts.

 

Jennifer Motles, Chief Sustainability Officer of PMI, stated, "We are humbled to have received the 'Triple-A' recognition from CDP for the second time. External validation from organizations like CDP encourages us to continue our journey towards creating a net positive impact on society.

 

PMI is one of only 14 companies in the world to receive an esteemed A rating in all three categories, making it one of the most innovative companies globally in terms of environmental transparency and performance.

 

Massimo Andolina, Senior Vice President of Operations at PMI, stated: "As a company with a multinational footprint, we have a role to play in protecting the planet and remain committed to being at the forefront of climate neutrality.

 

By acknowledging that PMI is a leader in climate action, CDP encourages us to continue our efforts. We have defined and implemented strategies and measures to reduce our environmental impact across the entire value chain. We believe that it is essential to collaborate with tobacco growers, suppliers, retailers, non-governmental organizations, and governments to implement adaptation and mitigation measures throughout the value chain in order to enhance our resilience to climate risks.

 

In November, PMI released its Low Carbon Transition Plan (LCTP) to help address the climate crisis. The plan provides transparent and detailed information about how the company intends to achieve its climate ambitions, measure success, and report progress.

 

This strategy was shaped by the company's sustainability importance assessment, which PMI used to reevaluate which sustainability topics should be prioritized in order to help meet stakeholder expectations and focus on areas where it can create value and have the greatest impact.

 

Motles added: "As we continue to transform our business, it remains crucial to clearly and transparently disclose our progress.

 

This will help us make better preparations and adaptability, identify and respond to the growing risks, and find new opportunities for action that global investors, consumers, and other key stakeholders demand. However, if we are to play a role in addressing the climate crisis, this is also the right thing to do.

 

LCTP is part of the company's broader sustainability strategy, which is focused on addressing the impact of its products and successfully phasing out cigarettes to achieve a smoke-free future as quickly as possible.

 

Original article link:

 

PMI (Philip Morris International) has achieved a triple A rating for the second consecutive year from CDP (Carbon Disclosure Project).

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
The Volume Illusion: Measuring the Future of Nicotine with the Tools of the Past
The Volume Illusion: Measuring the Future of Nicotine with the Tools of the Past
As next-generation nicotine products become economically central rather than marginal, traditional volume-based metrics are increasingly unable to explain consumption, risk, and value. Units designed for a cigarette-based economy struggle to describe systems defined by delivery speed, pharmacokinetics, and adaptive user behavior. Drawing on financial reporting, regulation, and nicotine science, a fundamental question: can the future of nicotine still be measured using the tools of its past?
Feb.09 by Alan Zhao | 2Firsts Perspectives
Kyrgyzstan: Jogorku Kenesh committee sends draft vape ban bills back for revisions
Kyrgyzstan: Jogorku Kenesh committee sends draft vape ban bills back for revisions
Kyrgyzstan Jogorku Kenesh committee on labor, health, women’s affairs and social issues decided to withdraw for revision two draft laws related to banning electronic nicotine delivery systems and e-cigarettes in Kyrgyzstan.
Jan.14 by 2FIRSTS.ai
Malaysia’s Perak Health Department says seized vape-related items valued at RM2,738 during two-week operation
Malaysia’s Perak Health Department says seized vape-related items valued at RM2,738 during two-week operation
Malaysia’s Perak State Health Department said it carried out a two-week joint enforcement operation from January 1 to 14, 2026, in line with the state government’s policy prohibiting renewals of vape sales licences effective January 1.
Jan.20 by 2FIRSTS.ai
Syria announces comprehensive ban on e-cigarettes covering production, trade, sale and use
Syria announces comprehensive ban on e-cigarettes covering production, trade, sale and use
Syria Damascus health authorities announced a comprehensive ban on e-cigarettes, prohibiting their production, circulation, sale and use, citing health risks and the need to protect public health, particularly among children and young people.
Mar.02 by 2FIRSTS.ai
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
A Fifth Circuit panel upheld the U.S. Food and Drug Administration’s 2021 final rule requiring companies seeking premarket authorization for new tobacco products to include information on health-risk investigations. In a published opinion, the court found FDA satisfied the Regulatory Flexibility Act’s procedural requirements and reasonably relied on the economic analysis from the 2016 “deeming rule” as a factual basis to certify limited impact on small businesses.
Feb.27 by 2FIRSTS.ai